Literature DB >> 12750705

Aberrant methylation and impaired expression of the p15(INK4b) cell cycle regulatory gene in chronic myelomonocytic leukemia (CMML).

M Tessema1, F Länger, J Dingemann, A Ganser, H Kreipe, U Lehmann.   

Abstract

The important cell cycle regulatory gene p15(INK4b) has been shown to be inactivated in acute myeloid leukemia and myelodysplastic syndrome. Little is known about the expression and epigenetic modification of this gene in chronic myelomonocytic leukemia (CMML) that belongs to the myelodysplastic/myeloproliferative disorders (MDS/MPD) with a high proportion of blastic transformation. Analysis of bone marrow trephines in a series of 33 CMML cases showed an aberrant p15(INK4b) gene methylation in up to 58% of cases. Methylation was analyzed employing different methylation-specific PCR and genomic sequencing protocols. It turned out to be spread over a broad area of the 5' region and exhibited substantial heterogeneity between cases and even in individual patients. The degree of aberrant methylation was correlated with a reduced mRNA as well as reduced protein expression, and was associated with a higher expression of DNA methyltransferase DNMT 3A. We conclude that aberrant gene methylation is a frequent event in CMML that might contribute to the pathogenesis of this MDS/MPD.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12750705     DOI: 10.1038/sj.leu.2402891

Source DB:  PubMed          Journal:  Leukemia        ISSN: 0887-6924            Impact factor:   11.528


  16 in total

1.  Myeloid-specific inactivation of p15Ink4b results in monocytosis and predisposition to myeloid leukemia.

Authors:  Juraj Bies; Marek Sramko; Joanna Fares; Michael Rosu-Myles; Steven Zhang; Richard Koller; Linda Wolff
Journal:  Blood       Date:  2010-05-10       Impact factor: 22.113

2.  Aberrant methylation and downregulation of sall3 in human hepatocellular carcinoma.

Authors:  Xue-Xi Yang; Jing-Zhe Sun; Fen-Xia Li; Ying-Song Wu; Hong-Yan Du; Wei Zhu; Xiang-Hong Li; Ming Li
Journal:  World J Gastroenterol       Date:  2012-06-07       Impact factor: 5.742

Review 3.  Epigenetic inactivation of tumor suppressor genes in hematologic malignancies.

Authors:  Tomohiro Kinoshita
Journal:  Int J Hematol       Date:  2004-08       Impact factor: 2.490

4.  Archival bone marrow trephines are suitable for high-throughput mutation analysis using next generation sequencing technology.

Authors:  Britta Hasemeier; Robert Geffers; Stephan Bartels; Brigitte Schlegelberger; Hans Kreipe; Ulrich Lehmann
Journal:  Haematologica       Date:  2013-09       Impact factor: 9.941

5.  DNA methylation profile in chronic myelomonocytic leukemia associates with distinct clinical, biological and genetic features.

Authors:  Laura Palomo; Roberto Malinverni; Marta Cabezón; Blanca Xicoy; Montserrat Arnan; Rosa Coll; Helena Pomares; Olga García; Francisco Fuster-Tormo; Javier Grau; Evarist Feliu; Francesc Solé; Marcus Buschbeck; Lurdes Zamora
Journal:  Epigenetics       Date:  2018-02-06       Impact factor: 4.528

6.  Aberrant DNA methyltransferase 1 expression in clear cell renal cell carcinoma development and progression.

Authors:  Ming Li; Ying Wang; Yongsheng Song; Renge Bu; Bo Yin; Xiang Fei; Qizhen Guo; Bin Wu
Journal:  Chin J Cancer Res       Date:  2014-08       Impact factor: 5.087

7.  Histone deacetylase inhibitor romidepsin has differential activity in core binding factor acute myeloid leukemia.

Authors:  Olatoyosi M Odenike; Serhan Alkan; Dorie Sher; John E Godwin; Dezheng Huo; Stephen J Brandt; Margaret Green; Jingping Xie; Yanming Zhang; David H Vesole; Patrick Stiff; John Wright; Richard A Larson; Wendy Stock
Journal:  Clin Cancer Res       Date:  2008-11-01       Impact factor: 12.531

8.  Identification of differentially expressed microRNAs in human male breast cancer.

Authors:  Ulrich Lehmann; Thomas Streichert; Benjamin Otto; Cord Albat; Britta Hasemeier; Henriette Christgen; Elisa Schipper; Ursula Hille; Hans H Kreipe; Florian Länger
Journal:  BMC Cancer       Date:  2010-03-23       Impact factor: 4.430

9.  MDS and secondary AML display unique patterns and abundance of aberrant DNA methylation.

Authors:  Maria E Figueroa; Lucy Skrabanek; Yushan Li; Anchalee Jiemjit; Tamer E Fandy; Elisabeth Paietta; Hugo Fernandez; Martin S Tallman; John M Greally; Hetty Carraway; Jonathan D Licht; Steven D Gore; Ari Melnick
Journal:  Blood       Date:  2009-08-03       Impact factor: 22.113

Review 10.  Cell cycle and no end.

Authors:  Mathewos Tessema; Ulrich Lehmann; Hans Kreipe
Journal:  Virchows Arch       Date:  2004-02-17       Impact factor: 4.064

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.